VUSV - ETF AI Analysis
Top Page
Vanguard Wellington U.S. Value Active ETF (VUSV)
Rating:67Neutral
Price Target:―
Positive Factors
Balanced Sector Mix
The fund spreads its investments across many sectors like financials, technology, health care, and industrials, which helps reduce the impact if any one industry struggles.
Several Strong-Performing Holdings
Some key positions such as Merck, Schlumberger, ASML, Chubb, and Dover have shown strong or steady performance, helping offset weaker names in the portfolio.
Moderate Expense Ratio for Active Management
The ETF’s fee is relatively modest for an actively managed strategy, which helps investors keep more of any returns over time.
Negative Factors
Recent Weak Performance
The fund has shown weak returns over the past month and year-to-date, which may concern investors looking for near-term strength.
Underperforming Mega-Cap Tech Holdings
Several of the largest technology-related holdings, including Amazon, Microsoft, and Alphabet, have recently lagged, putting pressure on overall results.
Heavy U.S. Concentration
With almost all assets in U.S. companies and very little overseas exposure, the fund is highly tied to the health of the U.S. market.
VUSV vs. SPDR S&P 500 ETF (SPY)
AUM70.54M
RegionNorth America
Expense Ratio0.30%
Beta0.64
IssuerVanguard
Inception DateNov 14, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,394
30 Day Avg. Volume8,219
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
78.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering86
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VUSV Summary
Vanguard Wellington U.S. Value Active ETF (VUSV) is an actively managed fund that invests mainly in U.S. companies the managers believe are undervalued based on their business results. It doesn’t track a fixed index, but focuses on the total U.S. stock market with a value theme across many sectors like financials, technology, and health care. Well-known holdings include Amazon and Microsoft. Someone might invest in VUSV for long-term growth and diversification while focusing on stocks that may be priced lower than their potential. A key risk is that these value stocks can still fall in price and move up and down with the overall market.
How much will it cost me?The Vanguard Wellington U.S. Value Active ETF (VUSV) has an expense ratio of 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Vanguard Wellington U.S. Value Active ETF (VUSV) could benefit from a strong U.S. economy, as its focus on undervalued companies across sectors like financials, healthcare, and technology may lead to growth opportunities. However, rising interest rates or economic slowdowns could negatively impact its financial and industrial holdings, while regulatory changes in healthcare or technology might also pose risks. Its active management approach provides flexibility to adapt to market changes, but it may underperform if value stocks fall out of favor.
VUSV Top 10 Holdings
VUSV’s story is a U.S.-only value tilt wrapped in some very familiar growth names. ASML and Schlumberger have been the real engines lately, with strong, rising momentum that gives the fund a helpful push from semiconductors and energy. On the defensive side, Merck and UnitedHealth are quietly steady, adding healthcare ballast. Alphabet is still a bright spot with solid recent gains, while Amazon has been more mixed and losing a bit of steam in the near term. Financials like Morgan Stanley provide additional support, though Wells Fargo has been lagging and slightly weighing on results.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amazon | 3.15% | $2.19M | $2.56T | 13.26% | 71 Outperform | |
| Alphabet Class A | 3.14% | $2.19M | $4.30T | 102.83% | 85 Outperform | |
| Microsoft | 2.61% | $1.82M | $2.95T | -17.02% | 79 Outperform | |
| Merck & Company | 2.42% | $1.68M | $294.13B | 47.59% | 80 Outperform | |
| ASML Holding | 2.31% | $1.61M | $665.15B | 121.17% | 81 Outperform | |
| Schlumberger | 2.25% | $1.57M | $82.99B | 57.17% | 75 Outperform | |
| Chubb | 2.05% | $1.43M | $128.22B | 13.36% | 80 Outperform | |
| Morgan Stanley | 1.98% | $1.38M | $325.96B | 56.66% | 76 Outperform | |
| UnitedHealth | 1.85% | $1.29M | $370.03B | 27.93% | 72 Outperform | |
| Wells Fargo | 1.77% | $1.23M | $250.84B | 10.76% | 80 Outperform |
VUSV Technical Analysis
Positive
―
Price Trends
66.10
Positive
65.15
Positive
Market Momentum
0.48
Positive
60.19
Neutral
51.83
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VUSV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 67.23, equal to the 50-day MA of 66.10, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.48 indicates Positive momentum. The RSI at 60.19 is Neutral, neither overbought nor oversold. The STOCH value of 51.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VUSV.
VUSV Peer Comparison
Comparison Results
Performance Comparison
VUSV
Vanguard Wellington U.S. Value Active ETF
68.10
8.85
14.94%
GMOV
GMO US Value ETF
―
―
―
SASS
M.D. Sass Concentrated Value ETF
―
―
―
GVLE
Goldman Sachs Value Opportunities ETF
―
―
―
CVAR
Cultivar ETF
―
―
―
USFE
First Eagle US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents